Two Ohio doctors and their clinics disciplined over weight loss drugsJanuary 28, 2025#Ohio#BOP#glp1-agonist#weight-loss#unapproved-drugs#backfilled·ohiocapitaljournal.com·Mar 27, 2025Two Ohio doctors and their clinics disciplined over weight loss drugs
OAC and TOS urge FDA to enforce GLP-1s compounding regulationsMarch 24, 2025#Compounding#glp1-agonist#United-States#FDA#backfilled·bariatricnews.net·Mar 24, 2025OAC and TOS urge FDA to enforce GLP-1s compounding regulations
Compounded Zepbound alternatives disappear : Shots - Health News : NPRMarch 19, 2025#Compounding#glp1-agonist#Zepbound#backfilled·npr.org·Mar 21, 2025Compounded Zepbound alternatives disappear : Shots - Health News : NPR
FBI warns about counterfeit weight loss drugsMarch 18, 2025#North-Carolina#glp1-agonist#FBI#Shabbir-quote#backfilled·wsoctv.com·Mar 18, 2025FBI warns about counterfeit weight loss drugs
FBI gives new warning about fake weight loss drugs being sold in GeorgiaMarch 14, 2025#counterfeit-injections#glp1-agonist#Shabbir-quote#FBI#Georgia#Compounding#backfilled·wsbtv.com·Mar 17, 2025FBI gives new warning about fake weight loss drugs being sold in Georgia
Pharmacy Quality Assurance Commission issues Limited Stop Service on license of pharmacy | Washington State Department of HealthMarch 13, 2025#glp1-agonist#Compounding#aequita-pharmacy#backfilled·doh.wa.gov·Mar 14, 2025Pharmacy Quality Assurance Commission issues Limited Stop Service on license of pharmacy | Washington State Department of Health
Mark Baughman: The hidden dangers of compounded medicines — a call for cautionMarch 12, 2025#op-ed#glp1-agonist#Compounding#backfilled·floridapolitics.com·Mar 13, 2025Mark Baughman: The hidden dangers of compounded medicines — a call for caution
The end of compounded GLP-1s: What physicians need to knowMarch 13, 2025#glp1-agonist#Compounding#United-States#backfilled·medscape.com·Mar 13, 2025The end of compounded GLP-1s: What physicians need to know
Warning Letter USApeptide.com - MARC-CMS 696885February 26, 2025#Warning-letters#FDA#semaglutide#tirzepatide#misbranded-drugs#unapproved-drugs#glp1-agonist#backfilled·fda.gov·Mar 12, 2025Warning Letter USApeptide.com - MARC-CMS 696885
US judge denies injunction, restricting copies of Lilly weight-loss drugMarch 6, 2025#Compounding#tirzepatide#Zepbound#Mounjaro#United-States#glp1-agonist#backfilled·yahoo.com·Mar 10, 2025US judge denies injunction, restricting copies of Lilly weight-loss drug
Public health group warns about fake weight loss drugs | Fox 59March 4, 2025#counterfeit-injections#glp1-agonist#Shabbir-quote#misbranded#backfilled·fox59.com·Mar 7, 2025Public health group warns about fake weight loss drugs | Fox 59
Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patientsMarch 5, 2025#Novo-Nordisk#Wegovy#United-States#glp1-agonist#backfilled·prnewswire.com·Mar 5, 2025Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients
SecuringIndustry.com - Illegal weight-loss ingredients are 'flooding into US'February 25, 2025#glp1-agonist#Shabbir-quote#backfilled·securingindustry.com·Feb 28, 2025SecuringIndustry.com - Illegal weight-loss ingredients are 'flooding into US'
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’February 28, 2025#glp1-agonist#backfilled·mmm-online.com·Feb 28, 2025Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’
Hims & Hers warns it may stop selling compounded weight-loss drugsFebruary 24, 2025#glp1-agonist#Compounding#semaglutide#Hims&Hers#backfilled·reuters.com·Feb 25, 2025Hims & Hers warns it may stop selling compounded weight-loss drugs
FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDAMarch 10, 2025 (updated)#semaglutide#drug-shortages#FDA#glp1-agonist#backfilled·fda.gov·Feb 24, 2025FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA
Semaglutide shortage ends as FDA sets deadline for compounders - Pharmaceutical TechnologyFebruary 24, 2025#semaglutide#Compounding#glp1-agonist#backfilled·pharmaceutical-technology.com·Feb 24, 2025Semaglutide shortage ends as FDA sets deadline for compounders - Pharmaceutical Technology
Attorneys general urge FDA to crack down on counterfeit obesity drugsFebruary 20, 2025#glp1-agonist#counterfeit-drugs#backfilled·statnews.com·Feb 21, 2025Attorneys general urge FDA to crack down on counterfeit obesity drugs
Coalition urges FDA to act as report finds illegal GLP-1 ingredients ‘flooding’ into US - BioSpaceFebruary 21, 2025#glp1-agonist#APIs#backfilled·biospace.com·Feb 21, 2025Coalition urges FDA to act as report finds illegal GLP-1 ingredients ‘flooding’ into US - BioSpace
GLP-1 DrugsFebruary 19, 2025#glp1-agonist#counterfeit-injections#Mounjaro#Zepbound#Ozempic#Wegovy#Insulin#FDA#APIs#Compounding#backfilled·naag.org·Feb 20, 2025GLP-1 Drugs
Armed bandits in Brazil pursue new loot: OzempicFebruary 15, 2025#Brazil#glp1-agonist#pharmacy-theft#backfilled·nytimes.com·Feb 19, 2025Armed bandits in Brazil pursue new loot: Ozempic
SF-based company airs controversial Super Bowl ad despite objectionsFebruary 9, 2025#glp1-agonist#semaglutide#Shabbir-quote#backfilled·sfgate.com·Feb 10, 2025SF-based company airs controversial Super Bowl ad despite objections
Pharmacies require stricter weight-loss jab checksFebruary 3, 2025#online-pharmacies#glp1-agonist#United-Kingdom#patient-safety#backfilled·bbc.com·Feb 4, 2025Pharmacies require stricter weight-loss jab checks
GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedationJanuary 28, 2025#United-Kingdom#glp1-agonist#warning#backfilled·gov.uk·Jan 28, 2025GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
Patients are flocking to compounded weight-loss drugs, but are they safe? | Diabetes | JAMA | JAMA NetworkJanuary 24, 2025#JAMA#glp1-agonist#Compounding#backfilled·jamanetwork.com·Jan 27, 2025Patients are flocking to compounded weight-loss drugs, but are they safe? | Diabetes | JAMA | JAMA Network
Increase regulation of online sale of weight-loss jabs, pharmacists sayJanuary 27, 2025#United-Kingdom#glp1-agonist#online-sales#backfilled·theguardian.com·Jan 27, 2025Increase regulation of online sale of weight-loss jabs, pharmacists say
Warning Letter www.weightcrunchshop.com - MARCS-CMS 695815January 13, 2025#FDA#Warning-letters#semaglutide#misbranded#unapproved#glp1-agonist#backfilled·fda.gov·Jan 22, 2025Warning Letter www.weightcrunchshop.com - MARCS-CMS 695815
Big Brother star ‘nearly died’ after taking fake OzempicJanuary 21, 2025#glp1-agonist#Ozempic#black-market#United-Kingdom#backfilled·people.com·Jan 21, 2025Big Brother star ‘nearly died’ after taking fake Ozempic
Mapping the effectiveness and risks of GLP-1 receptor agonistsReceived: June 14, 2024 Accepted November 12, 2024#glp1-agonist#research-paper#backfilled·nature.com·Jan 21, 2025Mapping the effectiveness and risks of GLP-1 receptor agonists
FDA says the Zepbound shortage is over. Here's what the means for compounding pharmacies, patients who used off-brand versionsDecember 24, 2024#FDA#tirzepatide#shortage#Zepbound#semaglutide#Compounding#glp1-agonist#backfilled·cnbc.com·Dec 24, 2024FDA says the Zepbound shortage is over. Here's what the means for compounding pharmacies, patients who used off-brand versions